Canada Survey of Pharmaceutical Diversion: Annual Report 2017

Quarter Benzo diazepines Hydro morphone Oxy codone Other* Fentanyl Codeine Morphine Methyl phenidate Methadone Gabapentin Ampheta mines Bupre norphine Pregabalin Cannabinoid Hydro codone Oxy morphone Tapentadol 1Q17 49 25 33 24 12 15 10 11 1 7 2 1 4 3 1 2Q17 43 51 28 34 16 17 12 4 15 10 1 5 4 1 1 3Q17 35 26 26 10 65 16 7 7 6 3 6 2 2 1 4Q17 39 36 31 43 6 17 17 9 8 2 11 6 2 1 1 49 43 35 39 25 51 26 36 33 28 26 31 24 34 10 43 12 16 65 6 15 17 16 17 10 12 7 17 11 4 7 9 1 15 6 8 7 10 3 2 2 1 6 11 1 5 2 6 4 4 2 2 3 1 1 1 0 1 0 0 1 0 0 0 0 0 0 1 0 10 20 30 40 50 60 70 1Q17 2Q17 3Q17 4Q17 Drug Mentions by Quarter 1Q17-4Q17 Benzodiazepines Hydromorphone Oxycodone Other Fentanyl Codeine Morphine Methylphenidate Methadone Gabapentin Amphetamines Buprenorphine Pregabalin Cannibinoid Hydrocodone Oxymorphone Tapentadol *The most commonly mentioned other drugs include quetiapine, trazodone, and medications used to treat erectile dysfunction (sildenafil and tadalafil).

RkJQdWJsaXNoZXIy NDE4MDg=